These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 6129159)

  • 21. [Comparative study of the effects of fluphenazine-depot and flupenthixol-depot in the treatment of schizophrenic psychoses].
    Bilikiewicz A; Sep-Kowalikowa B
    Psychiatr Pol; 1976; 10(4):359-66. PubMed ID: 981411
    [No Abstract]   [Full Text] [Related]  

  • 22. [Current concepts of the effects of neuroleptics].
    Kostowski W; Płaźnik A
    Psychiatr Pol; 1990; 24(5):28-37. PubMed ID: 1983397
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical trial of flupenthixol decanoate in chronic withdrawn schizophrenic patients.
    Vichaiya V
    J Med Assoc Thai; 1980 Apr; 63(4):205-9. PubMed ID: 6991627
    [No Abstract]   [Full Text] [Related]  

  • 24. Central dopaminergic mechanisms in schizophrenia.
    Owen F; Crow TJ; Poulter M
    Acta Psychiatr Belg; 1987; 87(5):552-65. PubMed ID: 2897760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flupenthixol decanoate (fluanxol depot) in the treatment of chronic schizophrenic patients.
    Haider I
    J Pak Med Assoc; 1985 Sep; 35(9):286-9. PubMed ID: 3934417
    [No Abstract]   [Full Text] [Related]  

  • 26. [Physiopathology of schizophrenia. Some biologic aspects].
    Tissot R
    Schweiz Arch Neurol Neurochir Psychiatr; 1984; 135(1):29-40. PubMed ID: 6148787
    [No Abstract]   [Full Text] [Related]  

  • 27. Mechanism of the antipsychotic effect in the treatment of acute schizophrenia.
    Johnstone EC; Crow TJ; Frith CD; Carney MW; Price JS
    Lancet; 1978 Apr; 1(8069):848-51. PubMed ID: 76797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flupentixol and flupentixol decanoate, with special reference to their antipsychotic effect.
    Gottfries CG
    Acta Psychiatr Belg; 1974 Sep; 74(5):507-16. PubMed ID: 4620362
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical physiognomy of flupentixol.
    Gunby B
    Acta Psychiatr Belg; 1974 Sep; 74(5):500-6. PubMed ID: 4471030
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical and electoencephalographical studies of the thioxanthenes.
    Holden JM
    Acta Psychiatr Belg; 1974 Sep; 74(5):526-8. PubMed ID: 4471033
    [No Abstract]   [Full Text] [Related]  

  • 31. Schizophrenia.
    Bladessarini RJ
    N Engl J Med; 1977 Nov; 297(18):988-95. PubMed ID: 20577
    [No Abstract]   [Full Text] [Related]  

  • 32. Neuroleptic treatments and overflow movements in schizophrenia: are they independent?
    D'Agati E; Casarelli L; Pitzianti M; Pasini A
    Psychiatry Res; 2012 Dec; 200(2-3):970-6. PubMed ID: 22901438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Etiopathogenesis and treatment of psychosis.
    Crow TJ; Harrington CA
    Annu Rev Med; 1994; 45():219-34. PubMed ID: 7911014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiautistic effect of flupentixol.
    De Buck RP
    Acta Psychiatr Belg; 1974 Sep; 74(5):520-5. PubMed ID: 4471032
    [No Abstract]   [Full Text] [Related]  

  • 35. [Studies on the long acting neuroleptic agent flupenthixol decanoate--a review (author's transl)].
    Sieberns S
    Pharmakopsychiatr Neuropsychopharmakol; 1978 Jul; 11(4):186-98. PubMed ID: 674354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine and schizophrenia--proof at last?
    Harrison PJ
    Lancet; 2000 Sep; 356(9234):958-9. PubMed ID: 11041394
    [No Abstract]   [Full Text] [Related]  

  • 37. The neuropathology of schizophrenia.
    Stevens JR
    Psychol Med; 1982 Nov; 12(4):695-700. PubMed ID: 7156246
    [No Abstract]   [Full Text] [Related]  

  • 38. [Experience with depot neuroleptics].
    Arató M; Erdós A
    Orv Hetil; 1979 Apr; 120(17):1015-21. PubMed ID: 372888
    [No Abstract]   [Full Text] [Related]  

  • 39. [Flupenthixol--a partial atypical neuroleptic?].
    Kühn KU; Meyer K; Maier W
    Fortschr Neurol Psychiatr; 2000 Apr; 68 Suppl 1():S38-41. PubMed ID: 10907612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Dopaminergic receptor activity and the evolution of schizophrenia].
    Fodoreanu L
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1985; 30(2):131-4. PubMed ID: 2864729
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.